NCT02841215View on ClinicalTrials.gov

Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted Scabies

PHASE3CompletedINTERVENTIONAL

Enrollment

133

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

January 12, 2022

Study Completion Date

January 12, 2022

Conditions

GaleSevere Forms of ScabiesOral Parasitic DrugIvermectin

Interventions

DRUG

Ivermectin 200 µg/kg

Oral ivermectin 200 µg/kg three times (D0, D7 and D14) + topical treatment (permethrin 5% cream) on skin, hair and genital organs (D0 and D7) + emollient cream (Dexeryl® or other) daily on skin (D0 to D28)

DRUG

Ivermectin 400 µg/kg

Oral ivermectin 400 µg/kg three times (D0, D7 and D14) + topical treatment (permethrin 5% cream) on skin, hair and genital organs (D0 and D7) + emollient cream (Dexeryl® or other)daily on skin (D0 to D28)

Trial Locations (1)

94010

Henri Mondor Hospital, Créteil

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02841215 - Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted Scabies | Biotech Hunter | Biotech Hunter